tiprankstipranks
Advertisement
Advertisement
PTHS Earnings this Week: How Will it Perform?
PremiumPre-EarningsPTHS Earnings this Week: How Will it Perform?
7d ago
Pelthos Therapeutics initiated with an Overweight at Piper Sandler
Premium
The Fly
Pelthos Therapeutics initiated with an Overweight at Piper Sandler
25d ago
Pelthos Therapeutics price target lowered to $55 from $57 at Roth Capital
Premium
The Fly
Pelthos Therapeutics price target lowered to $55 from $57 at Roth Capital
26d ago
Pelthos Therapeutics secures up to $50M senior secured term loan
PremiumThe FlyPelthos Therapeutics secures up to $50M senior secured term loan
2M ago
Pelthos Therapeutics Details Q1 2026 Growth Strategy
Premium
Company Announcements
Pelthos Therapeutics Details Q1 2026 Growth Strategy
2M ago
Pelthos Therapeutics: Xeglyze Acquisition and Dermatology Portfolio Drive Multi‑Year Upside and Support Buy Rating
Premium
Ratings
Pelthos Therapeutics: Xeglyze Acquisition and Dermatology Portfolio Drive Multi‑Year Upside and Support Buy Rating
3M ago
Pelthos signs benefit manager agreement expanding patient access to ZELSUVMI
PremiumThe FlyPelthos signs benefit manager agreement expanding patient access to ZELSUVMI
4M ago
Lake Street starts Pelthos with a Buy on ‘category-leader potential’
Premium
The Fly
Lake Street starts Pelthos with a Buy on ‘category-leader potential’
4M ago
Pelthos Therapeutics initiated with a Buy at Lake Street
Premium
The Fly
Pelthos Therapeutics initiated with a Buy at Lake Street
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100